UltraSPECT's Adds Half-Dose Imaging Feature to Xpress.Cardiac

UltraSPECT's half-dose imaging feature is an addition to the capabilities available on the Xpress.Cardiac, its half-time WBR image reconstruction product. This new feature can minimize radiation exposure to patients, maximizing safety for both patients and staff.

With this new, FDA-approved feature, the Xpress.Cardiac now provides nuclear medicine cardiology practitioners with flexibility in both dose and acquisition time management. Depending on the patient and the physician’s preference, the rest/stress studies can be acquired using either half the radiopharmaceutical dose or half the scan time.

For more information: www.ultraspect.com